What is ICH and GCP? Understanding the International Council for Harmonisation
If you have recently started exploring clinical research, whether as a nurse, a physician, a study coordinator, or someone considering a career in this field, you have almost certainly encountered two acronyms that appear constantly: ICH and GCP. They seem to be used interchangeably, combined, and then separated again in genuinely confusing ways, especially when you are new to the field.
What does ICH stand for? What does GCP stand for? Are ICH and GCP the same thing? Is ICH GCP one concept or two? What is the full form of GCP in medical terms, and does it mean the same thing in a nursing context as it does in a pharmaceutical company? These are the questions that trip up nearly every beginner, and the answers matter more than you might think. Getting this terminology right is not just a matter of vocabulary. It is the foundation of understanding how clinical trials are regulated, why your training requirements exist, and what certification you actually need.
This guide answers every one of those questions clearly and completely, in plain language, so that you leave with a solid understanding of both ICH and GCP, how they relate to each other, and what that means for your career in clinical research.
What does GCP stand for? The full form of GCP in medical terms
GCP stands for Good Clinical Practice. That is the full form of GCP in medical terms, and it applies equally across pharmaceutical research, clinical trials, nursing practice within trial settings, and regulatory submissions worldwide.
In its broadest sense, Good Clinical Practice is a set of internationally recognized ethical and scientific quality standards for designing, conducting, recording, and reporting clinical trials that involve human participants. The central purpose of GCP is twofold: to protect the rights, safety, and well-being of trial participants, and to ensure that the data generated during a trial are credible, reliable, and accepted by regulatory authorities around the world.
Good Clinical Practice is not a single document or a single organization’s policy. It is a quality framework that has been developed and refined over decades, built on ethical principles that trace back to landmark documents including the Nuremberg Code, the Declaration of Helsinki, and the Belmont Report. To understand the full ethical heritage behind GCP, our guide to the Belmont Report explains how those foundational principles continue to shape clinical research today.
What GCP does, in practical terms, is define what sponsors, investigators, ethics committees, and regulatory authorities are each responsible for during a clinical trial. It covers informed consent, protocol design, adverse event reporting, data documentation, monitoring, and audit trails. Every stage of a clinical trial, from the first participant enrolled to the final data submission, is governed by these standards.
What is GCP in nursing?
GCP in a nursing context means the same thing as GCP in any other clinical research role. Nurses who work as principal investigators, sub-investigators, or clinical research coordinators at trial sites are required to understand and apply Good Clinical Practice standards in everything they do on a study, from obtaining informed consent to documenting study procedures and reporting adverse events.
In fact, GCP compliance is not optional for any healthcare professional who participates in a clinical trial, regardless of their professional background. A nurse working as a study coordinator at a trial site is subject to the same ICH GCP requirements as the principal investigator and the sponsor’s monitoring team. Our overview of principal investigator responsibilities under ICH GCP explains how delegation of responsibility works across a trial team and why every team member, clinical background or not, must be properly trained.
Good Clinical Practice training is increasingly required by hospitals, universities, and healthcare organizations as a standard qualification for anyone participating in research, making ICH GCP certification relevant not just to pharmaceutical industry professionals but also to any clinician who wants to be involved in clinical trials.
What does ICH stand for? Understanding the International Council for Harmonisation
ICH stands for the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. That is the full name, which explains why the abbreviation is so common. It is a long title with a precise meaning: this is an international body dedicated to harmonizing the technical and scientific requirements that pharmaceutical products must meet before they can be registered and approved by regulatory authorities in different countries.
How was ICH founded?
ICH was established in 1990 by representatives from the regulatory authorities and pharmaceutical industry associations of the three major pharmaceutical markets at the time: the United States, the European Union, and Japan. The founding logic was straightforward. Before ICH existed, a pharmaceutical company that wanted to register a new drug in the US, Europe, and Japan often had to conduct separate sets of clinical trials for each region, because each regulatory authority had its own specific requirements. That meant duplicating clinical trials on human subjects, wasting enormous resources, and slowing down the availability of medicines to patients.
ICH was created to solve that problem by developing unified technical guidelines that regulatory authorities across member regions would recognize and accept. If a clinical trial is conducted according to ICH standards, the data generated in that trial should be acceptable to regulators in any ICH member country, without needing to be repeated.
What does ICH do?
ICH develops guidelines across four main areas: quality guidelines, relating to pharmaceutical quality systems and chemistry, manufacturing, and controls; safety guidelines, covering preclinical testing; efficacy guidelines, covering clinical trial design, conduct, and reporting; and multidisciplinary guidelines that cut across the other categories.
The guidelines are developed through a rigorous consensus process involving both regulators and industry experts. Once a guideline is finalized at the ICH level, the regulatory authorities in member regions, including the FDA in the United States, the EMA in the European Union, and Health Canada, adopt it into their own regulatory frameworks. Over 60 countries now implement ICH guidelines either directly or as the basis for their own national regulations.
ICH member regions and observers currently include regulatory bodies from the US, EU, Japan, Switzerland, Canada, China, South Korea, Brazil, and many others, making it a genuinely global standard-setting body.
What does ICH mean in GCP?
When you see the term ICH GCP, it means that the GCP standards being referenced are those specifically developed and published by ICH, as opposed to GCP requirements that might come from a national regulatory authority alone. ICH in GCP is essentially a qualifier that tells you which version of Good Clinical Practice is being applied.
This distinction matters because GCP as a broad concept exists in many forms. Individual countries and regulatory bodies have developed their own GCP frameworks. The US FDA has GCP requirements embedded in its regulations under 21 CFR Parts 50, 56, and 312. The European Union has GCP requirements in its Clinical Trial Regulation. Japan has GCP guidelines issued by MHLW. These national frameworks existed before ICH was founded, and they still exist today.
ICH GCP refers specifically to the ICH guideline on Good Clinical Practice, which is published under the code ICH E6 within the ICH efficacy guideline series. The “E” stands for Efficacy, and the “6” is simply the sequential number of this particular guideline within that series. When you see ICH GCP, ICH E6, or ICH GCP E6, they all refer to the same international document. You can explore the official ICH guidelines and the ICH E6(R3) document on the ICH website directly.
The reason ICH GCP is so important in practice is that it provides the common, internationally agreed standard that sponsors, CROs, and investigators follow when conducting trials that will be submitted to regulatory authorities in multiple countries. If a company wants its trial data accepted by both the FDA and the EMA, the trial must be conducted in accordance with ICH GCP. That makes ICH GCP the default expectation in almost every industry-sponsored clinical trial globally.
What is the difference between ICH and GCP?
This is the question that confuses most beginners, and the confusion is understandable because ICH and GCP are genuinely different and are almost always used together.
ICH is an organization, a standard-setting body that brings together regulators and industry to create harmonized guidelines.
GCP is a concept, a quality and an ethical framework for conducting clinical trials involving human participants.
ICH GCP is a specific document, the guideline published by ICH that defines how Good Clinical Practice should be implemented in clinical trials, with the aim of ensuring participant protection and data integrity at an international level.
The simplest way to think about it: ICH is who made the rules. GCP is what the rules are about. ICH GCP is the specific rulebook that ICH published.
Are ICH and GCP the same thing?
No, ICH and GCP are not the same thing, but they are deeply connected. ICH is the organization; GCP is the standard. When people say ICH GCP, they mean the version of Good Clinical Practice that ICH has defined in its E6 guideline.
In everyday professional use, the term ICH GCP is so common that many people use it as a single phrase without separating the two components. Saying “I am trained in ICH GCP” means you have completed training based on the ICH E6 guideline on Good Clinical Practice. It does not mean you have been trained separately by ICH as an organization. ICH does not deliver training directly; it publishes guidelines that training programs, like those offered here at PharmaEduCenter, use as their curriculum.
GCP as a broad concept vs. ICH GCP as a specific document
One of the most useful distinctions to understand is the one between GCP used broadly and ICH GCP used specifically.
GCP, used broadly, describes any set of standards that a research institution, regulatory authority, or sponsor considers to represent good practice in clinical research. Your hospital’s research department might have its own GCP-aligned standard operating procedures. The NIH encourages researchers to follow GCP principles for all NIH-funded clinical trials. An academic research center might train its staff in GCP concepts without specifically mandating ICH E6 compliance for every study.
ICH GCP, used specifically, refers to the ICH E6 document. When a sponsor’s clinical trial agreement requires ICH GCP compliance, when a monitoring visit checklist references ICH GCP requirements, or when a regulatory authority’s inspection criteria cite ICH GCP, they are referring to the ICH E6 guideline. This is the standard your ICH GCP certification is built on.
The practical implication: if you are working on an industry-sponsored clinical trial or any trial whose data will be submitted to a regulatory authority like the FDA or EMA, you will almost certainly need to comply with ICH GCP specifically, not just GCP in a general sense.
How ICH GCP works: the E6 guideline explained
The ICH E6 guideline is structured around responsibilities. It defines what sponsors are responsible for, what investigators are responsible for, what ethics committees must do, and how monitoring and auditing should work. It covers every major domain of clinical trial conduct, including protocol design, informed consent, investigational product management, data integrity, adverse event reporting, and essential document maintenance.
Our dedicated guide to What is Good Clinical Practice goes deeper into the content and principles of GCP itself, and our article on the principles of ICH GCP explains how those principles have evolved under the most recent revision.
ICH E6(R3): the latest version
The ICH E6 guideline has been revised twice since its original publication in 1996. The first major revision, E6(R2), was published in 2016 and included an addendum addressing the growing use of electronic systems, risk-based approaches to monitoring, and the increasing complexity of multinational trials. Our article on key changes between ICH GCP E6 R2 and R3 explains exactly how the guideline has evolved.
The most recent revision, ICH E6(R3), was finalized on January 6, 2025, and represents the most significant rewrite of the guideline in its history. E6(R3) is not an addendum to the previous version; it is a complete restructuring of the entire document, with a new framework that explicitly embraces quality-by-design, proportionate oversight, decentralized trial models, and a modernized approach to data governance. The FDA adopted E6(R3) in September 2025.
For anyone currently holding a Good Clinical Practice certification based on E6(R2), this transition is important. The ICH GCP training and certification landscape has shifted substantially, and our ICH GCP certification renewal guide covers what changed and what it means for your recertification requirements.
Why ICH GCP matters in practice
ICH GCP matters because it is the condition under which the world’s regulatory authorities will accept clinical trial data. Without ICH GCP-compliant data, a pharmaceutical company cannot obtain FDA or EMA approval for a new drug. Without ICH GCP-trained personnel, a clinical trial site cannot be added to a sponsor’s approved site list. Without ICH GCP documentation practices, a monitoring visit or regulatory inspection will find critical deficiencies that can invalidate data or halt a trial.
The stakes are not abstract. Our article on good documentation practice and the connection between documentation standards and data integrity shows precisely why ICH GCP requirements for record-keeping exist and what happens when they are not followed. Our guide on adverse event reporting in clinical trials explains how ICH GCP defines the timelines and responsibilities for safety reporting, one of the most scrutinized areas of GCP compliance.
Who needs to comply with ICH GCP?
ICH GCP applies to every person who plays a defined role in a clinical trial that generates data for regulatory submission. That includes sponsors and their staff, contract research organizations (CROs), principal investigators and sub-investigators, clinical research coordinators, clinical research associates, data managers, pharmacists managing investigational products, and ethics committee members who review trial protocols.
If you are involved in setting up a clinical trial site for the first time, our complete course on how to set up a clinical trial site explains the ICH GCP requirements that apply from the moment you agree to participate in a study. And if you are exploring how to become a principal investigator or what it takes to lead a clinical trial site, ICH GCP training is the essential starting point.
ICH GCP compliance is not limited to the pharmaceutical industry. Clinical researchers in academic medical centers, hospital-based research units, and university research programs who conduct interventional trials with investigational products are expected to follow ICH GCP when their trial involves data for regulatory submission. The NIH requires ICH GCP training for all staff involved in NIH-funded clinical trials to promote these standards even outside the commercial sector.
ICH GCP in nursing and allied health
For nurses and allied health professionals working in research settings, ICH GCP training is increasingly a non-negotiable requirement. Whether you are a research nurse managing participant visits at a Phase III trial site, a nurse practitioner acting as a sub-investigator, or a hospital pharmacist overseeing investigational product storage and accountability, your role falls within the ICH GCP framework.
GCP in nursing means applying the same standards of documentation, informed consent practice, adverse event recognition and reporting, and protocol adherence that apply to any other trial team member. Many nurses find that their clinical training gives them a strong foundation for GCP compliance, particularly in areas like participant safety monitoring and communication. What formal ICH GCP training adds is the regulatory structure: who is responsible for what, what the documentation requirements are, and what the consequences of non-compliance look like during a monitoring visit or inspection.
Understanding that GCP in nursing is not a separate, softer version of the standard, but the same internationally recognized ICH GCP framework applied to a clinical role, is an important professional clarity for anyone coming into research from a healthcare background.
How to get ICH GCP certified
ICH GCP certification means completing an accredited training program based on the ICH E6 guideline and receiving a certificate that confirms your training, the guideline version you were trained on, and the date of completion. Sponsors and CROs use this certificate to verify that investigators and site staff are qualified to participate in a trial.
Our ICH GCP E6(R3) Good Clinical Practice certification course is fully accredited by the Faculty of Pharmaceutical Medicine of the Royal College of Physicians (UK) and approved by TransCelerate BioPharma, making it one of the most recognized ICH GCP certifications available globally. If you are an investigator or site team member, our dedicated ICH GCP training for investigators and site personnel is tailored specifically to the responsibilities defined under ICH GCP for clinical site teams.
For professionals who are new to clinical research entirely, our Fundamentals of Clinical Trials course provides the complete foundational knowledge you need before stepping into a clinical trial role, covering both what ICH GCP requires and how trials are structured from design through to reporting.
Our guide on how to get ICH GCP certification explains the full process, what to look for in a GCP course, how long certification is valid for, and when refresher training is appropriate. And if you are already certified and wondering whether you need a full recertification or just a refresher, our article on ICH GCP refresher training vs full ICH GCP certification gives you the answer clearly.
Key takeaways
- GCP stands for Good Clinical Practice, the international ethical and scientific quality standard for designing, conducting, recording, and reporting clinical trials involving human subjects.
- ICH stands for the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, the international organization that develops harmonized guidelines for pharmaceutical development and regulation.
- ICH GCP refers specifically to the Good Clinical Practice guideline published by ICH under the code ICH E6, the document that defines how GCP must be implemented in clinical trials whose data will be submitted to international regulatory authorities.
- ICH and GCP are not the same thing: ICH is the organization, GCP is the quality framework, and ICH GCP is the specific document that combines both.
- The most current version of ICH GCP is E6(R3), finalized in January 2025 and adopted by the FDA in September 2025.
- GCP applies equally to all clinical trial professionals regardless of background, including nurses, physicians, pharmacists, coordinators, and data managers.
- ICH GCP certification is the professional qualification that confirms your training on the ICH E6 guideline, and it is required for participation in the vast majority of industry-sponsored clinical trials worldwide.
Conclusion
If you walked into this article confused about what ICH and GCP are, you now have the clarity you need to move forward confidently. ICH is the body that created the standard. GCP is the standard. ICH GCP is the specific, internationally recognized guideline that governs how clinical trials must be conducted to protect participants and generate credible data. These are not interchangeable terms but connected concepts, and understanding that connection is the first step toward working competently in clinical research.
Whether you are a nurse entering trial work for the first time, a physician considering becoming a principal investigator, a coordinator starting your career in clinical research, or an experienced professional updating your knowledge to reflect the E6(R3) transition, ICH GCP training and certification is the foundation that everything else is built on.
The good news is that getting certified has never been more accessible. Our courses are online, self-paced, and internationally accredited, designed specifically for the clinical research professionals who need this knowledge to do their jobs well.
Are you ready to get your ICH GCP certification?
Join more than 6,000 professionals from over 70 countries who have earned their ICH GCP certification with PharmaEduCenter. Our fully accredited, TransCelerate-approved ICH GCP training course is available online, 24/7, at your own pace, with an internationally recognized certificate upon completion. Whether you are a first-time learner or an experienced professional updating to E6(R3), we have the course that fits your needs.
Click here to explore our courses and get certified today.
FAQ: What is ICH and GCP?
What does ICH stand for in clinical trials?
ICH stands for the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. It is the international body that brings together regulatory authorities and pharmaceutical industry associations to develop harmonized guidelines for pharmaceutical development, including the ICH GCP E6 guideline that governs the conduct of clinical trials.
What does GCP stand for in medical terms?
GCP stands for Good Clinical Practice. In medical and clinical research contexts, it refers to the international ethical and scientific quality standard for designing, conducting, recording, and reporting clinical trials involving human participants. The full form of GCP in medical terms is always Good Clinical Practice, regardless of which regulatory framework or organization is applying it.
What is the difference between ICH and GCP?
ICH is an organization, the International Council for Harmonisation. GCP is a quality framework, Good Clinical Practice. ICH GCP is the specific document published by ICH under the code E6 that defines how Good Clinical Practice should be implemented in clinical trials. ICH created the document; GCP is what the document is about.
Are ICH and GCP the same thing?
No. ICH and GCP are not the same thing, though they are closely connected. ICH is the organization that publishes guidelines. GCP is the standard for conducting ethical clinical trials. When people say “ICH GCP,” they mean the version of Good Clinical Practice defined by ICH in its E6 guideline, which is the internationally recognized standard for clinical trial conduct.
What does ICH mean in GCP?
In the context of Good Clinical Practice, ICH means that the GCP standards being applied are those specifically defined by the International Council for Harmonisation in its E6 guideline. The term ICH GCP distinguishes the internationally harmonized standard from GCP requirements that might come from a single national regulatory authority, such as the FDA alone or the EMA alone.
What is the current version of ICH GCP?
The current version is ICH GCP E6(R3), which was finalized by ICH on January 6, 2025. It replaces the previous version, E6(R2), which had been in effect since 2016. The FDA adopted ICH E6(R3) as official guidance in September 2025. This version introduces a fully restructured framework that incorporates quality-by-design, risk-based oversight, and provisions for decentralized and technology-enabled clinical trials.
Is ICH GCP training required for nurses?
Yes. Nurses and other allied health professionals who participate in clinical trials as investigators, sub-investigators, study coordinators, or research nurses are required to complete ICH GCP training in accordance with sponsor requirements and applicable regulations. GCP in nursing is not a different or lighter standard; it is the same internationally recognized ICH GCP framework that applies to all members of a clinical trial team.
How long is ICH GCP certification valid?
ICH GCP certification is typically valid for two to three years, depending on sponsor requirements, institutional policies, and the country in which you are working. With the adoption of ICH E6(R3) in 2025, many sponsors are requiring updated training to ensure all certified staff are familiar with the new framework. Our ICH GCP certification renewal guide explains the renewal timelines and how to determine what training you need.
